Clinical trial
Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia
NCT00749970 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2008
- Completion date
- January 31, 2009
- Enrollment
- 100 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
schizoaffective disorder, schizophrenia, schizophreniform disorder